+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Metabolomics Market 2019-2023 - Product Image

Global Metabolomics Market 2019-2023

  • ID: 4749671
  • Report
  • January 2019
  • Region: Global
  • 112 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Bruker
  • METABOLON
  • MORE

High potential for new techniques in metabolomics to emerge as a major trend. New techniques in metabolomics are gaining widespread popularity among scientists and researchers due to their increased potential for fast and simultaneous fingerprinting of a vast number of metabolites. Many of the above professionals use multiple separation techniques such as high-performance liquid chromatography (HPLC), UPLC, ion chromatography-mass spectrometry (IC-MS), GC, and LC, and other detection techniques such as MS-NMR, surface-based mass analysis, and metabolite profiling for successful and comprehensive metabolite coverage. The analysts have predicted that the metabolomics market will register a CAGR of nearly 12% by 2023.

Market Overview

Rising demand for early and accurate diagnosis

In recent years, the field of metabolomics has shown significant potential in early disease diagnosis, therapy monitoring, and understanding the pathogenesis of different diseases. Since metabolomics methods focus on analytical techniques such as N MR spectroscopy and MS, the analyses from these high-resolution methods using advanced chemometric approaches can provide a powerful platform for translational/clinical research and diagnostic applications.

Lack of skilled professionals

Research analysis of samples using metabolomics tools requires the assistance of skilled professionals to design experiments, collect the samples, extract the samples, and generate metabolomic data. These professionals must have in-depth knowledge of analytical methods such as mass spectrometry and nuclear magnetic resonance, which are used in performing experiments.

For the detailed list of factors that will drive and challenge the growth of the metabolomics market during the 2019-2023, view this report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Bruker and Human Metabolome Technologies, the competitive environment is quite intense. Factors such as the rising demand for early and accurate diagnosis and the high potential for new techniques in metabolomics, will provide considerable growth opportunities to metabolomics manufacturers. Agilent Technologies, Bio-Rad Laboratories, Bruker, Human Metabolome Technologies, and METABOLON are some of the major companies covered in this report.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Bruker
  • METABOLON
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
  • Market segmentation by application
  • Comparison by application
  • Biomarker and drug discovery - Market size and forecast 2018-2023
  • Nutrigenomics - Market size and forecast 2018-2023
  • Toxicology testing - Market size and forecast 2018-2023
  • Market opportunity by application
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 10: MARKET TRENDS
  • Increasing applications of metabolomics
  • High potential for new techniques in metabolomics
  • New developments in the field of metabolomics
PART 11: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 12: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Bruker
  • Human Metabolome Technologies
  • METABOLON
PART 13: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Years in consideration
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Application - Market share 2018-2023 (%)
Exhibit 19: Comparison by application
Exhibit 20: Biomarker and drug discovery - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Biomarker and drug discovery - Year-over-year growth 2019-2023 (%)
Exhibit 22: Nutrigenomics - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Nutrigenomics - Year-over-year growth 2019-2023 (%)
Exhibit 24: Toxicology testing - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Toxicology testing - Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by application
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America - Year-over-year growth 2019-2023 (%)
Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 34: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Decision framework
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Agilent Technologies - Vendor overview
Exhibit 48: Agilent Technologies - Business segments
Exhibit 49: Agilent Technologies - Organizational developments
Exhibit 50: Agilent Technologies - Geographic focus
Exhibit 51: Agilent Technologies - Segment focus
Exhibit 52: Agilent Technologies - Key offerings
Exhibit 53: Bio-Rad Laboratories - Vendor overview
Exhibit 54: Bio-Rad Laboratories - Business segments
Exhibit 55: Bio-Rad Laboratories - Organizational developments
Exhibit 56: Bio-Rad Laboratories - Geographic focus
Exhibit 57: Bio-Rad Laboratories - Segment focus
Exhibit 58: Bio-Rad Laboratories - Key offerings
Exhibit 59: Bruker - Vendor overview
Exhibit 60: Bruker - Business segments
Exhibit 61: Bruker - Organizational developments
Exhibit 62: Bruker - Geographic focus
Exhibit 63: Bruker - Segment focus
Exhibit 64: Bruker - Key offerings
Exhibit 65: Human Metabolome Technologies - Vendor overview
Exhibit 66: Human Metabolome Technologies - Business segments
Exhibit 67: Human Metabolome Technologies - Organizational developments
Exhibit 68: Human Metabolome Technologies - Key offerings
Exhibit 69: METABOLON - Vendor overview
Exhibit 70: METABOLON - Business segments
Exhibit 71: METABOLON - Organizational developments
Exhibit 72: METABOLON - Key offerings
Exhibit 73: Validation techniques employed for market sizing
Exhibit 74: List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Bruker
  • METABOLON
  • MORE
Global Metabolomics Market 2019-2023

The analyst recognizes the following companies as the key players in the global metabolomics market: Agilent Technologies, Bio-Rad Laboratories, Bruker, Human Metabolome Technologies, and METABOLON.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the high potential for new techniques in metabolomics.”

According to the report, one of the major drivers for this market is the rising demand for early and accurate diagnosis.

Further, the report states that one of the major factors hindering the growth of this market is the lack of skilled professionals.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Bruker
  • Human Metabolome Technologies
  • METABOLON
Note: Product cover images may vary from those shown
Adroll
adroll